Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future of medical technology ...

“I was scared to death to do that,” she said. Her last treatment in 2020 was Keytruda, a prescription immunotherapy drug used to treat many types of cancer. Gemberling is currently in remissio ...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, ...

With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement. RAHWAY: Merck, also known as MSD outside the US and ...

Merck's diversified pipeline includes promising oncology candidates and a new pneumococcal vaccine, but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless of ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

People with relapsed or treatment-resistant classic Hodgkin Lymphoma now have FDA approval to use Keytruda. The immunotherapy treatment is proven to extend life. “The FDA approval is welcome news and ...

Columbia University is the top college in New York state, followed by Colgate University and Cornell University, in the Wall Street Journal/College Pulse 2025 Best Colleges in the U.S. ranking ...

Columbia University is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Columbia University confers degrees through various schools, such as: the ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to ...